{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T15:50:50Z","timestamp":1789314650960,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T00:00:00Z","timestamp":1214438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00228-008-0513-7","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T09:05:47Z","timestamp":1214384747000},"page":"921-929","source":"Crossref","is-referenced-by-count":50,"title":["Incidence and risk factors for agranulocytosis in Latin American countries\u2014the Latin Study"],"prefix":"10.1007","volume":"64","author":[{"given":"Nelson","family":"Hamerschlak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Maluf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Biasi Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Avezum J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Eluf-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Passeto Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Gyongyv\u00e9r Heidemarie","family":"Lorand-Metze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9zar","family":"Leite Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"de Oliveira Werneck Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leny","family":"Nascimento da Motta Passos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Oliveira de Miranda Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carolina","family":"Tostes Pint\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lio","family":"Moraes de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Rafael","family":"Borbolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,26]]},"reference":[{"issue":"8","key":"513_CR1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.165.8.869","volume":"165","author":"L Ib\u00e1\u00f1ez","year":"2005","unstructured":"Ib\u00e1\u00f1ez L, Vidal X, Ballar\u00edn E, Laporte JR (2005) Population-based drug-induced agranulocytosis. Arch Intern Med 165(8):869\u2013874","journal-title":"Arch Intern Med"},{"issue":"12","key":"513_CR2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.1994.03510360061038","volume":"271","author":"NS Young","year":"1994","unstructured":"Young NS (1994) Agranulocytosis. JAMA 271(12):935\u2013938","journal-title":"JAMA"},{"key":"513_CR3","doi-asserted-by":"crossref","unstructured":"Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA 256(13):1749\u20131757","DOI":"10.1001\/jama.1986.03380130077032"},{"issue":"5","key":"513_CR4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1590\/S1516-31802005000500009","volume":"123","author":"N Hamerschlak","year":"2005","unstructured":"Hamerschlak N, Cavalcanti AB (2005) Neutropenia, agranulocytosis and dipyrone. Sao Paulo Med J 123(5):247\u2013249","journal-title":"Sao Paulo Med J"},{"key":"513_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0609.1996.tb01641.x","volume":"60","author":"DW Kaufman","year":"1996","unstructured":"Kaufman DW, Kelly JP, Jurgelon JM et al (1996) Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl 60:23\u201330","journal-title":"Eur J Haematol Suppl"},{"key":"513_CR6","volume-title":"The drug etiology of agranulocytosis and aplastic anemia: the international agranulocytosis and aplastic anemia study","author":"DW Kaufman","year":"1991","unstructured":"Kaufman DW, Kelly JP, Levy M, Shapiro S (1991) The drug etiology of agranulocytosis and aplastic anemia: the international agranulocytosis and aplastic anemia study. New York, Oxford University Press"},{"issue":"9","key":"513_CR7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146(9):657\u2013665","journal-title":"Ann Intern Med"},{"issue":"11","key":"513_CR8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00228-004-0836-y","volume":"60","author":"L Ib\u00e1\u00f1ez","year":"2005","unstructured":"Ib\u00e1\u00f1ez L, Vidal X, Ballar\u00edn E, Laporte JR (2005) Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol 60(11):821\u2013829","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"513_CR9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4269\/ajtmh.1999.60.573","volume":"60","author":"S Shapiro","year":"1999","unstructured":"Shapiro S, Issaragrisil S, Kaufman DW et al (1999) Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg 60(4):573\u2013577","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"513_CR10","first-page":"294","volume":"111","author":"N Hamerschlak","year":"1993","unstructured":"Hamerschlak N, Montezuma MP, Bacal N et al (1993) Retrospective prevalence and incidence of drug-induced agranulocytosis in the city of S\u00e3o Paulo-Brazil. Rev Paul Med 111(1):294\u2013298","journal-title":"Rev Paul Med"},{"issue":"3","key":"513_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1590\/S1516-31802005000300002","volume":"123","author":"N Hamerschlak","year":"2005","unstructured":"Hamerschlak N, Maluf E, Pasquini R et al (2005) Incidence of aplastic anemia and agranulocytosis in Latin America\u2013the LATIN study. Sao Paulo Med J 123(3):101\u2013104","journal-title":"Sao Paulo Med J"},{"key":"513_CR12","unstructured":"Hennekens CH, Buring JE (1987) Measures of disease frequency. In: Hennekens CH, Buring E (eds) Epidemiology in medicine. Lippincott, Williams & Wilkins, Philadelphia"},{"issue":"2","key":"513_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-9343(90)90465-P","volume":"88","author":"LK Hine","year":"1990","unstructured":"Hine LK, Gerstman BB, Wise RP, Tsong Y (1990) Mortality resulting from blood dyscrasias in the United States, 1984. Am J Med 88(2):151\u2013153","journal-title":"Am J Med"},{"issue":"6","key":"513_CR14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.0954-6820.1979.tb06084.x","volume":"205","author":"LE B\u00f6ttiger","year":"1979","unstructured":"B\u00f6ttiger LE, Furhoff AK, Holmberg L (1979) Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee. Acta Med Scand 205(6):457\u2013461","journal-title":"Acta Med Scand"},{"issue":"4","key":"513_CR15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.0954-6820.1979.tb13504.x","volume":"206","author":"P Arneborn","year":"1979","unstructured":"Arneborn P, Palmblad J (1979) Drug-induced neutropenias in the Stockholm region 1976\u20131977. Acta Med Scand 206(4):241\u2013243","journal-title":"Acta Med Scand"},{"issue":"5","key":"513_CR16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.0954-6820.1982.tb03216.x","volume":"212","author":"P Arneborn","year":"1982","unstructured":"Arneborn P, Palmblad J (1982) Drug-induced neutropenia\u2013a survey for Stockholm 1973\u20131978. Acta Med Scand 212(5):289\u2013292","journal-title":"Acta Med Scand"},{"issue":"3","key":"513_CR17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00228-006-0242-8","volume":"63","author":"N Tavassoli","year":"2007","unstructured":"Tavassoli N, Duchayne E, Sadaba B et al (2007) Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 63(3):221\u2013228","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"513_CR18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejim.2006.07.012","volume":"17","author":"E Andr\u00e8s","year":"2006","unstructured":"Andr\u00e8s E, Zimmer J, Affenberger S et al (2006) Idiosyncratic drug-induced agranulocytosis: Update of an old disorder. Eur J Intern Med 17(8):529\u2013535","journal-title":"Eur J Intern Med"},{"issue":"3","key":"513_CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/S1516-31802005000300001","volume":"123","author":"IM Bense\u00f1or","year":"2005","unstructured":"Bense\u00f1or IM (2005) Dipyrone and blood dyscrasia revisited: \u201cnon-evidence based medicine\u201d. Sao Paulo Med J 123(3):99\u2013100","journal-title":"Sao Paulo Med J"},{"issue":"3","key":"513_CR20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1592\/phco.26.3.440","volume":"26","author":"S Garcia","year":"2006","unstructured":"Garcia S, Canionero M, Lopes G (2006) Dipyrone-induced granulocytopenia: a case for awareness. Pharmacotherapy 26(3):440\u2013442","journal-title":"Pharmacotherapy"},{"issue":"4","key":"513_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00228-002-0465-2","volume":"58","author":"K Hedenmalm","year":"2002","unstructured":"Hedenmalm K, Spigset O (2002) Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 58(4):265\u2013274","journal-title":"Eur J Clin Pharmacol"},{"key":"513_CR22","doi-asserted-by":"crossref","unstructured":"Carvalho-Silva DR, Santos FR, Rocha J, Pena SD (2001) The phylogeography of Brazilian Y-chromosome lineages. Am J Hum Genet 68(1):281\u2013286","DOI":"10.1086\/316931"},{"issue":"5","key":"513_CR23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.tpj.6500423","volume":"7","author":"M Dettling","year":"2007","unstructured":"Dettling M, Cascorbi I, Opgen-Rhein C, Schaub R (2007) Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens. Pharmacogenomics J 7(5):325\u2013332","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"513_CR24","first-page":"295","volume":"48","author":"Y G\u00fczelcan","year":"2006","unstructured":"G\u00fczelcan Y, Scholte WF (2006) Door clozapine ge\u00efnduceerde agranulocytose: genetische en immunologische verklaringen. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model]. Tijdschr Psychiatr 48(4):295\u2013302","journal-title":"Tijdschr Psychiatr"},{"key":"513_CR25","unstructured":"World Health Organization (2006) WHO Statistical Information System (WHOSIS). Core Health Indicators. World Health Organization. http:\/\/www.who.int\/whosis\/database\/core\/core_select.cfm . Accessed 15 Feb 2007"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-008-0513-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-008-0513-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-008-0513-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T21:18:06Z","timestamp":1709068686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-008-0513-7"}},"subtitle":["A multicenter study"],"short-title":[],"issued":{"date-parts":[[2008,6,26]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1007\/s00228-008-0513-7","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,26]]}}}